Lymphoma cell exposure to a low nanomolar concentration of dual PAK4-NAMPT inhibitor KPT-9274 (structure shown in Figure 1B) led to inhibition of cell proliferation (Figure 1C). Here, PAK4 is linked to lymphoma.